Sugammadex Injection
Product Images NDC 83301-0078

6 FDA label images from Mullan Pharmaceutical Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sugammadex (NDC 83301-0078). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mullan Pharmaceutical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sugammadex 01)

Chemical Structure (Sugammadex 01)
Chemical structure of Sugammadex Sodium, showing its cyclic molecular arrangement with multiple sodium carboxylate groups and sulfur atoms, consistent with its molecular configuration as represented in the product data.*
FDA Label Image

Chemical Structure (Sugammadex 02)

Chemical Structure (Sugammadex 02)
Chemical structure of Sugammadex Sodium, illustrating the detailed molecular composition of the active ingredient in the Sugammadex injection product by Mullan Pharmaceutical Inc.*
FDA Label Image

Figure 1 (Sugammadex 03)

Figure 1 (Sugammadex 03)
A cumulative recovery rate curve comparing sugammadex 2 mg/kg and neostigmine 0.05 mg/kg over time to recovery in minutes. The chart includes median recovery times and interquartile ranges for both treatments, illustrating a faster recovery with sugammadex. Censored observations are also indicated on the graph.*
FDA Label Image

Figure 2 (Sugammadex 04)

Figure 2 (Sugammadex 04)
A Kaplan-Meier plot showing the cumulative recovery rate over time in minutes for two treatments: sugammadex 2 mg/kg and neostigmine 0.05 mg/kg in patients given vecuronium. The graph includes a legend with median recovery times and quartiles for both drugs, illustrating the faster recovery associated with sugammadex.*
FDA Label Image

Principal Display Panel (2 mL Vial Carton)

Principal Display Panel (2 mL Vial Carton)
Packaging label for Sugammadex Injection 200 mg/2 mL (100 mg/mL) by Mullan Pharmaceutical Inc. The label states it is for intravenous use only, contains 10 single-dose 2 mL vials, and includes storage and manufacturing details. The label features the Mullan logo and a barcode.*
FDA Label Image

Principal Display Panel (5 mL Vial Carton)

Principal Display Panel (5 mL Vial Carton)
Sugammadex Injection 500 mg/5 mL (100 mg/mL) intravenous injection packaging label from Mullan Pharmaceutical Inc. The box contains 10 single-dose 5 mL vials. The label includes storage instructions, manufacturer information, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.